Certara, Inc. operates at scale within the healthcare information services sector, leveraging advanced biosimulation and regulatory expertise to accelerate drug development. Its integrated software and service offerings support clients from early-stage research through regulatory submission and commercialization. The company's global footprint and specialized focus provide a competitive advantage in the pharmaceutical R&D technology market.As of Friday, Certara shares were priced at $8.74, down 18% over the ...